Two-year outcomes of a randomized trial with the Superion InterSpinous Spacer were published in Spine.  The study concluded that the Superion InterSpinous Spacer relieves symptoms of intermittent neurogenic claudication secondary to moderate lumbar spinal stenosis in the majority of patients through 2 years.  Larry Miller, PhD of MSC serves as the corresponding author for this paper.  More.